NBLY — Neighbourly Pharmacy Cashflow Statement
0.000.00%
- CA$839.05m
- CA$1.17bn
- CA$749.15m
- 66
- 56
- 68
- 68
Annual cashflow statement for Neighbourly Pharmacy, fiscal year end - March 25th, CAD millions except per share, conversion factor applied.
2019 March 30th | 2020 March 28th | 2021 March 27th | 2022 March 26th | 2023 March 25th | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -22.8 | -23.3 | -90.5 | -72.4 | -14.8 |
| Depreciation | |||||
| Non-Cash Items | 18.9 | 26.8 | 99.5 | 66.2 | 15.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.91 | 10.6 | 8.91 | -8.12 | -10.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 14.8 | 27.9 | 37 | 11.1 | 49.7 |
| Capital Expenditures | -2.15 | -0.916 | -0.982 | -2.97 | -8.54 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -47.6 | -79.3 | -69.4 | -103 | -448 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -49.8 | -80.2 | -70.4 | -106 | -456 |
| Financing Cash Flow Items | -8.84 | -15.8 | -15.4 | 210 | 268 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 36.2 | 53.7 | 75.4 | 89.9 | 389 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.29 | 1.33 | 42 | -5.5 | -17.5 |